Unknown

Dataset Information

CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance.


ABSTRACT: Cancer stem-like cells (CSCs) are associated with cancer progression, metastasis, and recurrence, and may also represent a subset of circulating tumor cells (CTCs). In our prior study, CTCs in advanced prostate cancer patients were found to express CD117/c-kit in a liquid biopsy. Whether CD117 expression played an active or passive role in the aggressiveness and migration of these CTCs remained an open question. In this study, we show that CD117 expression in prostate cancer patients is associated with decreased overall and progression-free survival and that activation and phosphorylation of CD117 increases in prostate cancer patients with higher Gleason grades. To determine how CD117 expression and activation by its ligand stem cell factor (SCF, kit ligand, steel factor) alter prostate ca

SUBMITTER: Harris KS 

PROVIDER: S-EPMC7809150 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature